The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex
Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle def...
Ausführliche Beschreibung
Autor*in: |
Tee, Andrew R. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2016transfer abstract |
---|
Schlagwörter: |
---|
Umfang: |
9 |
---|
Übergeordnetes Werk: |
Enthalten in: Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate - Cho, Sung Beom ELSEVIER, 2014transfer abstract, London |
---|---|
Übergeordnetes Werk: |
volume:52 ; year:2016 ; pages:12-20 ; extent:9 |
Links: |
---|
DOI / URN: |
10.1016/j.semcdb.2016.01.040 |
---|
Katalog-ID: |
ELV035497769 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV035497769 | ||
003 | DE-627 | ||
005 | 20230625204457.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.semcdb.2016.01.040 |2 doi | |
028 | 5 | 2 | |a GBVA2016019000003.pica |
035 | |a (DE-627)ELV035497769 | ||
035 | |a (ELSEVIER)S1084-9521(16)30038-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 570 | |
082 | 0 | 4 | |a 570 |q DE-600 |
082 | 0 | 4 | |a 540 |q VZ |
082 | 0 | 4 | |a 500 |q VZ |
084 | |a 33.25 |2 bkl | ||
084 | |a 31.00 |2 bkl | ||
100 | 1 | |a Tee, Andrew R. |e verfasserin |4 aut | |
245 | 1 | 4 | |a The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex |
264 | 1 | |c 2016transfer abstract | |
300 | |a 9 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. | ||
520 | |a Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. | ||
650 | 7 | |a HME |2 Elsevier | |
650 | 7 | |a VZ |2 Elsevier | |
650 | 7 | |a TSC |2 Elsevier | |
650 | 7 | |a FCD |2 Elsevier | |
650 | 7 | |a CNS |2 Elsevier | |
650 | 7 | |a SEGA |2 Elsevier | |
650 | 7 | |a TLE |2 Elsevier | |
650 | 7 | |a RGC |2 Elsevier | |
650 | 7 | |a SVZ |2 Elsevier | |
650 | 7 | |a TAC |2 Elsevier | |
650 | 7 | |a IPC |2 Elsevier | |
650 | 7 | |a SEN |2 Elsevier | |
650 | 7 | |a mTORC |2 Elsevier | |
650 | 7 | |a NSC |2 Elsevier | |
700 | 1 | |a Sampson, Julian R. |4 oth | |
700 | 1 | |a Pal, Deb K. |4 oth | |
700 | 1 | |a Bateman, Joseph M. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Academic Press |a Cho, Sung Beom ELSEVIER |t Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate |d 2014transfer abstract |g London |w (DE-627)ELV017968445 |
773 | 1 | 8 | |g volume:52 |g year:2016 |g pages:12-20 |g extent:9 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.semcdb.2016.01.040 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OPC-MAT | ||
912 | |a GBV_ILN_70 | ||
936 | b | k | |a 33.25 |j Thermodynamik |j statistische Physik |q VZ |
936 | b | k | |a 31.00 |j Mathematik: Allgemeines |q VZ |
951 | |a AR | ||
952 | |d 52 |j 2016 |h 12-20 |g 9 | ||
953 | |2 045F |a 570 |
author_variant |
a r t ar art |
---|---|
matchkey_str |
teeandrewrsampsonjulianrpaldebkbatemanjo:2016----:hrlomosgalninuoeeiisgtfotbr |
hierarchy_sort_str |
2016transfer abstract |
bklnumber |
33.25 31.00 |
publishDate |
2016 |
allfields |
10.1016/j.semcdb.2016.01.040 doi GBVA2016019000003.pica (DE-627)ELV035497769 (ELSEVIER)S1084-9521(16)30038-6 DE-627 ger DE-627 rakwb eng 570 570 DE-600 540 VZ 500 VZ 33.25 bkl 31.00 bkl Tee, Andrew R. verfasserin aut The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex 2016transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. HME Elsevier VZ Elsevier TSC Elsevier FCD Elsevier CNS Elsevier SEGA Elsevier TLE Elsevier RGC Elsevier SVZ Elsevier TAC Elsevier IPC Elsevier SEN Elsevier mTORC Elsevier NSC Elsevier Sampson, Julian R. oth Pal, Deb K. oth Bateman, Joseph M. oth Enthalten in Academic Press Cho, Sung Beom ELSEVIER Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate 2014transfer abstract London (DE-627)ELV017968445 volume:52 year:2016 pages:12-20 extent:9 https://doi.org/10.1016/j.semcdb.2016.01.040 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT GBV_ILN_70 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 52 2016 12-20 9 045F 570 |
spelling |
10.1016/j.semcdb.2016.01.040 doi GBVA2016019000003.pica (DE-627)ELV035497769 (ELSEVIER)S1084-9521(16)30038-6 DE-627 ger DE-627 rakwb eng 570 570 DE-600 540 VZ 500 VZ 33.25 bkl 31.00 bkl Tee, Andrew R. verfasserin aut The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex 2016transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. HME Elsevier VZ Elsevier TSC Elsevier FCD Elsevier CNS Elsevier SEGA Elsevier TLE Elsevier RGC Elsevier SVZ Elsevier TAC Elsevier IPC Elsevier SEN Elsevier mTORC Elsevier NSC Elsevier Sampson, Julian R. oth Pal, Deb K. oth Bateman, Joseph M. oth Enthalten in Academic Press Cho, Sung Beom ELSEVIER Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate 2014transfer abstract London (DE-627)ELV017968445 volume:52 year:2016 pages:12-20 extent:9 https://doi.org/10.1016/j.semcdb.2016.01.040 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT GBV_ILN_70 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 52 2016 12-20 9 045F 570 |
allfields_unstemmed |
10.1016/j.semcdb.2016.01.040 doi GBVA2016019000003.pica (DE-627)ELV035497769 (ELSEVIER)S1084-9521(16)30038-6 DE-627 ger DE-627 rakwb eng 570 570 DE-600 540 VZ 500 VZ 33.25 bkl 31.00 bkl Tee, Andrew R. verfasserin aut The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex 2016transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. HME Elsevier VZ Elsevier TSC Elsevier FCD Elsevier CNS Elsevier SEGA Elsevier TLE Elsevier RGC Elsevier SVZ Elsevier TAC Elsevier IPC Elsevier SEN Elsevier mTORC Elsevier NSC Elsevier Sampson, Julian R. oth Pal, Deb K. oth Bateman, Joseph M. oth Enthalten in Academic Press Cho, Sung Beom ELSEVIER Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate 2014transfer abstract London (DE-627)ELV017968445 volume:52 year:2016 pages:12-20 extent:9 https://doi.org/10.1016/j.semcdb.2016.01.040 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT GBV_ILN_70 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 52 2016 12-20 9 045F 570 |
allfieldsGer |
10.1016/j.semcdb.2016.01.040 doi GBVA2016019000003.pica (DE-627)ELV035497769 (ELSEVIER)S1084-9521(16)30038-6 DE-627 ger DE-627 rakwb eng 570 570 DE-600 540 VZ 500 VZ 33.25 bkl 31.00 bkl Tee, Andrew R. verfasserin aut The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex 2016transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. HME Elsevier VZ Elsevier TSC Elsevier FCD Elsevier CNS Elsevier SEGA Elsevier TLE Elsevier RGC Elsevier SVZ Elsevier TAC Elsevier IPC Elsevier SEN Elsevier mTORC Elsevier NSC Elsevier Sampson, Julian R. oth Pal, Deb K. oth Bateman, Joseph M. oth Enthalten in Academic Press Cho, Sung Beom ELSEVIER Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate 2014transfer abstract London (DE-627)ELV017968445 volume:52 year:2016 pages:12-20 extent:9 https://doi.org/10.1016/j.semcdb.2016.01.040 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT GBV_ILN_70 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 52 2016 12-20 9 045F 570 |
allfieldsSound |
10.1016/j.semcdb.2016.01.040 doi GBVA2016019000003.pica (DE-627)ELV035497769 (ELSEVIER)S1084-9521(16)30038-6 DE-627 ger DE-627 rakwb eng 570 570 DE-600 540 VZ 500 VZ 33.25 bkl 31.00 bkl Tee, Andrew R. verfasserin aut The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex 2016transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. HME Elsevier VZ Elsevier TSC Elsevier FCD Elsevier CNS Elsevier SEGA Elsevier TLE Elsevier RGC Elsevier SVZ Elsevier TAC Elsevier IPC Elsevier SEN Elsevier mTORC Elsevier NSC Elsevier Sampson, Julian R. oth Pal, Deb K. oth Bateman, Joseph M. oth Enthalten in Academic Press Cho, Sung Beom ELSEVIER Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate 2014transfer abstract London (DE-627)ELV017968445 volume:52 year:2016 pages:12-20 extent:9 https://doi.org/10.1016/j.semcdb.2016.01.040 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT GBV_ILN_70 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 52 2016 12-20 9 045F 570 |
language |
English |
source |
Enthalten in Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate London volume:52 year:2016 pages:12-20 extent:9 |
sourceStr |
Enthalten in Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate London volume:52 year:2016 pages:12-20 extent:9 |
format_phy_str_mv |
Article |
bklname |
Thermodynamik statistische Physik Mathematik: Allgemeines |
institution |
findex.gbv.de |
topic_facet |
HME VZ TSC FCD CNS SEGA TLE RGC SVZ TAC IPC SEN mTORC NSC |
dewey-raw |
570 |
isfreeaccess_bool |
false |
container_title |
Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate |
authorswithroles_txt_mv |
Tee, Andrew R. @@aut@@ Sampson, Julian R. @@oth@@ Pal, Deb K. @@oth@@ Bateman, Joseph M. @@oth@@ |
publishDateDaySort_date |
2016-01-01T00:00:00Z |
hierarchy_top_id |
ELV017968445 |
dewey-sort |
3570 |
id |
ELV035497769 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV035497769</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625204457.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.semcdb.2016.01.040</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016019000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV035497769</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1084-9521(16)30038-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">570</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">500</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.25</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">31.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tee, Andrew R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HME</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VZ</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TSC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FCD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CNS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SEGA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TLE</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RGC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SVZ</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TAC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IPC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SEN</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">mTORC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NSC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sampson, Julian R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pal, Deb K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bateman, Joseph M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Cho, Sung Beom ELSEVIER</subfield><subfield code="t">Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate</subfield><subfield code="d">2014transfer abstract</subfield><subfield code="g">London</subfield><subfield code="w">(DE-627)ELV017968445</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:52</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:12-20</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.semcdb.2016.01.040</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-MAT</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.25</subfield><subfield code="j">Thermodynamik</subfield><subfield code="j">statistische Physik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">31.00</subfield><subfield code="j">Mathematik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">52</subfield><subfield code="j">2016</subfield><subfield code="h">12-20</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">570</subfield></datafield></record></collection>
|
author |
Tee, Andrew R. |
spellingShingle |
Tee, Andrew R. ddc 570 ddc 540 ddc 500 bkl 33.25 bkl 31.00 Elsevier HME Elsevier VZ Elsevier TSC Elsevier FCD Elsevier CNS Elsevier SEGA Elsevier TLE Elsevier RGC Elsevier SVZ Elsevier TAC Elsevier IPC Elsevier SEN Elsevier mTORC Elsevier NSC The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex |
authorStr |
Tee, Andrew R. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV017968445 |
format |
electronic Article |
dewey-ones |
570 - Life sciences; biology 540 - Chemistry & allied sciences 500 - Natural sciences & mathematics |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
570 570 DE-600 540 VZ 500 VZ 33.25 bkl 31.00 bkl The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex HME Elsevier VZ Elsevier TSC Elsevier FCD Elsevier CNS Elsevier SEGA Elsevier TLE Elsevier RGC Elsevier SVZ Elsevier TAC Elsevier IPC Elsevier SEN Elsevier mTORC Elsevier NSC Elsevier |
topic |
ddc 570 ddc 540 ddc 500 bkl 33.25 bkl 31.00 Elsevier HME Elsevier VZ Elsevier TSC Elsevier FCD Elsevier CNS Elsevier SEGA Elsevier TLE Elsevier RGC Elsevier SVZ Elsevier TAC Elsevier IPC Elsevier SEN Elsevier mTORC Elsevier NSC |
topic_unstemmed |
ddc 570 ddc 540 ddc 500 bkl 33.25 bkl 31.00 Elsevier HME Elsevier VZ Elsevier TSC Elsevier FCD Elsevier CNS Elsevier SEGA Elsevier TLE Elsevier RGC Elsevier SVZ Elsevier TAC Elsevier IPC Elsevier SEN Elsevier mTORC Elsevier NSC |
topic_browse |
ddc 570 ddc 540 ddc 500 bkl 33.25 bkl 31.00 Elsevier HME Elsevier VZ Elsevier TSC Elsevier FCD Elsevier CNS Elsevier SEGA Elsevier TLE Elsevier RGC Elsevier SVZ Elsevier TAC Elsevier IPC Elsevier SEN Elsevier mTORC Elsevier NSC |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
j r s jr jrs d k p dk dkp j m b jm jmb |
hierarchy_parent_title |
Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate |
hierarchy_parent_id |
ELV017968445 |
dewey-tens |
570 - Life sciences; biology 540 - Chemistry 500 - Science |
hierarchy_top_title |
Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV017968445 |
title |
The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex |
ctrlnum |
(DE-627)ELV035497769 (ELSEVIER)S1084-9521(16)30038-6 |
title_full |
The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex |
author_sort |
Tee, Andrew R. |
journal |
Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate |
journalStr |
Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
500 - Science |
recordtype |
marc |
publishDateSort |
2016 |
contenttype_str_mv |
zzz |
container_start_page |
12 |
author_browse |
Tee, Andrew R. |
container_volume |
52 |
physical |
9 |
class |
570 570 DE-600 540 VZ 500 VZ 33.25 bkl 31.00 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Tee, Andrew R. |
doi_str_mv |
10.1016/j.semcdb.2016.01.040 |
dewey-full |
570 540 500 |
title_sort |
role of mtor signalling in neurogenesis, insights from tuberous sclerosis complex |
title_auth |
The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex |
abstract |
Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. |
abstractGer |
Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. |
abstract_unstemmed |
Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT GBV_ILN_70 |
title_short |
The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex |
url |
https://doi.org/10.1016/j.semcdb.2016.01.040 |
remote_bool |
true |
author2 |
Sampson, Julian R. Pal, Deb K. Bateman, Joseph M. |
author2Str |
Sampson, Julian R. Pal, Deb K. Bateman, Joseph M. |
ppnlink |
ELV017968445 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth |
doi_str |
10.1016/j.semcdb.2016.01.040 |
up_date |
2024-07-06T17:42:55.306Z |
_version_ |
1803852474281361408 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV035497769</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625204457.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.semcdb.2016.01.040</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016019000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV035497769</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1084-9521(16)30038-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">570</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">500</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.25</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">31.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tee, Andrew R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HME</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VZ</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TSC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">FCD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CNS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SEGA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TLE</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RGC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SVZ</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TAC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IPC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SEN</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">mTORC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NSC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sampson, Julian R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pal, Deb K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bateman, Joseph M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Cho, Sung Beom ELSEVIER</subfield><subfield code="t">Spin-polarized bandgap of graphene induced by alternative chemisorption with MgO (111) substrate</subfield><subfield code="d">2014transfer abstract</subfield><subfield code="g">London</subfield><subfield code="w">(DE-627)ELV017968445</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:52</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:12-20</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.semcdb.2016.01.040</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-MAT</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.25</subfield><subfield code="j">Thermodynamik</subfield><subfield code="j">statistische Physik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">31.00</subfield><subfield code="j">Mathematik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">52</subfield><subfield code="j">2016</subfield><subfield code="h">12-20</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">570</subfield></datafield></record></collection>
|
score |
7.399727 |